| Year |
Citation |
Score |
| 2018 |
Vargas B, Giacobbi NS, Sanyal A, Venkatachari NJ, Han F, Gupta P, Sluis-Cremer N. Inhibitors of Signaling Pathways that Block Reversal of HIV-1 Latency. Antimicrobial Agents and Chemotherapy. PMID 30455231 DOI: 10.1128/Aac.01744-18 |
0.499 |
|
| 2017 |
Sanyal A, Mailliard RB, Rinaldo CR, Ratner D, Ding M, Chen Y, Zerbato JM, Giacobbi NS, Venkatachari NJ, Patterson BK, Chargin A, Sluis-Cremer N, Gupta P. Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4(+) T cells. Nature Medicine. PMID 28553933 DOI: 10.1038/Nm.4347 |
0.59 |
|
| 2016 |
Venkatachari NJ, Jain S, Walker L, Bivalkar-Mehla S, Chattopadhyay A, Bar-Joseph Z, Rinaldo C, Ragin A, Seaberg E, Levine A, Becker J, Martin E, Sacktor N, Ayyavoo V. Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men. Aids (London, England). PMID 28005686 DOI: 10.1097/Qad.0000000000001379 |
0.534 |
|
| 2016 |
Jain S, Arrais J, Venkatachari NJ, Ayyavoo V, Bar-Joseph Z. Reconstructing the temporal progression of HIV-1 immune response pathways. Bioinformatics (Oxford, England). 32: i253-i261. PMID 27307624 DOI: 10.1093/Bioinformatics/Btw254 |
0.361 |
|
| 2015 |
Venkatachari NJ, Zerbato JM, Jain S, Mancini AE, Chattopadhyay A, Sluis-Cremer N, Bar-Joseph Z, Ayyavoo V. Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch. Retrovirology. 12: 85. PMID 26438393 DOI: 10.1186/S12977-015-0211-3 |
0.551 |
|
| 2011 |
Chaipan C, Dilley KA, Paprotka T, Delviks-Frankenberry KA, Venkatachari NJ, Hu WS, Pathak VK. Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. Journal of Virology. 85: 4888-97. PMID 21325415 DOI: 10.1128/Jvi.00046-11 |
0.46 |
|
| 2010 |
Burdick R, Smith JL, Chaipan C, Friew Y, Chen J, Venkatachari NJ, Delviks-Frankenberry KA, Hu WS, Pathak VK. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. Journal of Virology. 84: 10241-53. PMID 20668078 DOI: 10.1128/Jvi.00585-10 |
0.583 |
|
| 2010 |
Venkatachari NJ, Walker LA, Tastan O, Le T, Dempsey TM, Li Y, Yanamala N, Srinivasan A, Klein-Seetharaman J, Montelaro RC, Ayyavoo V. Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles. Virology Journal. 7: 119. PMID 20529298 DOI: 10.1186/1743-422X-7-119 |
0.453 |
|
| 2010 |
Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, Hu WS, Pathak VK. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. Journal of Virology. 84: 5719-29. PMID 20335265 DOI: 10.1128/Jvi.00134-10 |
0.512 |
|
| 2009 |
Venkatachari NJ, Alber S, Watkins SC, Ayyavoo V. HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism. Plos One. 4: e7470. PMID 19829715 DOI: 10.1371/Journal.Pone.0007470 |
0.538 |
|
| 2009 |
Majumder B, Venkatachari NJ, Srinivasan A, Ayyavoo V. HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). Current Hiv Research. 7: 169-77. PMID 19275586 DOI: 10.2174/157016209787581445 |
0.594 |
|
| 2008 |
Venkatachari NJ, Buchanan WG, Ayyavoo V. Human immunodeficiency virus (HIV-1) infection selectively downregulates PD-1 expression in infected cells and protects the cells from early apoptosis in vitro and in vivo. Virology. 376: 140-53. PMID 18440040 DOI: 10.1016/J.Virol.2008.03.015 |
0.461 |
|
| 2008 |
Majumder B, Venkatachari NJ, O'Leary S, Ayyavoo V. Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells. Journal of Virology. 82: 7189-200. PMID 18417583 DOI: 10.1128/Jvi.01979-07 |
0.569 |
|
| 2007 |
Majumder B, Venkatachari NJ, Schafer EA, Janket ML, Ayyavoo V. Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha. Journal of Virology. 81: 7388-99. PMID 17475642 DOI: 10.1128/Jvi.00893-06 |
0.582 |
|
| 2007 |
Venkatachari NJ, Majumder B, Ayyavoo V. Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function. Virology. 358: 347-56. PMID 17023015 DOI: 10.1016/J.Virol.2006.08.030 |
0.589 |
|
| 2006 |
Schafer EA, Venkatachari NJ, Ayyavoo V. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR). Antiviral Research. 72: 224-32. PMID 16889838 DOI: 10.1016/J.Antiviral.2006.06.008 |
0.613 |
|
| Show low-probability matches. |